Concizumab

(Synonyms: NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia.

For research use only. We do not sell to patients.

  • Purity: 98.12%
  • CAS No.: 1312299-39-0
  • Molecular Weight:146.28 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Concizumab

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00